University of WashingtonSeattle, WA
Disclosures:
191 - Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer: FLARE-RT Mature Outcomes and Patterns of Failure
Monday, September 30, 202411:15 AM – 11:25 AM ET